Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) Current ratio

Solventum Corporation's current ratio at the end of the quarter to 30 June 2026 was 1.0×, down 0.2× from fiscal 2025 (1.2×). That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Annual

Period Current ratio Change
FY2025 1.2× 2.37%
FY2024 1.2× (17.55%)
FY2023 1.5× —

Quarterly

Period Current ratio Change
Jun 2026 1.0× (4.62%)
Mar 2026 1.1× (12.98%)
Dec 2025 1.2× (17.97%)
Sep 2025 1.5× 22.51%
7 more quarters

Current ratio against peers

Company Current ratio
RGEN Repligen Corporation compare 9.1×
WST West Pharmaceutical Services, Inc. compare 2.8×
ALC Alcon compare 2.1×
BAX Baxter International Inc. compare 1.9×
AVTR Avantor, Inc. compare 1.8×
ATR AptarGroup, Inc. compare 1.6×
ALGN Align Technology, Inc. compare 1.4×
COO The Cooper Companies, Inc. compare 1.2×
SOLV Solventum Corporation 1.0×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on SOLV